Consolidative therapy

DRUG2 trials

Sponsors

Sun Yat-sen University

Conditions

Lung Cancer (NSCLC)Small-Cell Lung Cancer (SCLC)

Phase 2

A Study Evaluating Concurrent Chemoradiotherapy Combined With Dual Immune Checkpoint Blockade for Limited-stage Small Cell Lung Cancer

Not yet recruitingNCT07103408

Sun Yat-sen UniversitySmall-Cell Lung Cancer (SCLC)

Start: 2025-10-01End: 2029-09-30Target: 56Updated: 2025-08-05

A Study Evaluating Neoadjuvant Chemotherapy, Concurrent Chemoradiotherapy Combined With Dual Immune Checkpoint Blockade in Patients With Locally Advanced Non-Small Cell Lung Cancer

RecruitingNCT07103395

Sun Yat-sen UniversityLung Cancer (NSCLC)

Start: 2026-01-01End: 2029-12-30Target: 56Updated: 2026-01-14